Riskpilot← Back to searchSign inGet full accessCerInvent AB
ABActiveOrg 5593111221Erik Dahlbergsgatan 11 AManufacture of medical and dental instruments and supplies · NACE 3250Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
-199% vs 2024
Equity ratio
87.9%
Financial strength
Net profit 2025
SEK -82K
-75% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -73K | -199% |
| Net profit | SEK -82K | -75% |
| Total assets | SEK 1,8M | -4% |
| Equity | SEK 1,6M | -5% |
| Employees | 0 | — |
Legal name
CerInvent AB
Org number
5593111221
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
9 april 2021
Share capital
SEK 48 250
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling, produktion, marknadsföring och försäljning av medicintekniska komponenter samt därmed förenlig verksamhet.
Address
Erik Dahlbergsgatan 11 A
Email
perhaag@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −264 | −156 | −1 | −0 |
| EBITDA | −464 | −139 | −24 | −73 |
| Depreciation & amort. | −24 | −35 | −35 | −35 |
| EBIT | −488 | −174 | −59 | −108 |
| Net financials | −0 | −0 | 1 | 5 |
| Profit before tax | −488 | −174 | −59 | −103 |
| Tax | 100 | 36 | 12 | 21 |
| Net profit | −388 | −138 | −47 | −82 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1 530 | 1 374 | 1 852 | 1 786 |
| Equity | 1 437 | 1 299 | 1 652 | 1 571 |
| Long-term debt | — | — | — | — |
| Short-term debt | 93 | 75 | 200 | 216 |
| Total debt | 93 | 75 | 200 | 216 |
EBITDA margin
-7259600.0%
This company
15.8%
Market median
-45946935% vs market
20222025
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
20222025
Return on equity
-5.2%
This company
18.4%
Market median
-128% vs market
20222025
Net profit margin
-8155900.0%
This company
8.1%
Market median
-100690223% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-09 – 2022-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CerInvent AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Margareta Fäldt | Board of Directors | 0 companies |
| Inger Helena Ströberg | Board of Directors | 0 companies |
| Annette Anna Wilhelmina Björklund | Chairman | 0 companies |
| Bengt Anders Waas | Deputy Board Member | 0 companies |
| Anette Helena Lundquist | Board of Directors | 0 companies |
| Stefan Erik Anders Edgren | Board of Directors | 0 companies |
| Per Åke Vult von Steyern | Board of Directors | 0 companies |
| Per Åke Allan Haag | Board of Directors | 0 companies |